Tirze-Pep 10
Tirzepatide
Tirzepatide — Tirze-Pep 10mg by Dragon Pharma
Tirze-Pep 10mg is Dragon Pharma's high-concentration formulation of Tirzepatide — the same dual GLP-1/GIP receptor agonist as the standard Tirze-Pep vial, supplied at double the concentration for users on advanced maintenance protocols. A single 10mg vial covers a wider dosing range without requiring multiple smaller vials, making it more practical for users who have titrated up to higher weekly doses.
Also searched as: Tirzepatide 10mg, Tirze-Pep 10mg vial, high-dose tirzepatide, GLP-1 GIP 10mg peptide.
What Is Tirzepatide 10mg?
Tirzepatide is a synthetic peptide activating both GLP-1 and GIP receptors — a dual mechanism that slows gastric emptying, increases satiety and improves insulin sensitivity. The 10mg vial contains the identical active substance as the 5mg version, simply at double the concentration. This does not change the compound's mechanism or effects at a given dose — it changes how much total Tirzepatide is available per vial, which is relevant for users on higher maintenance doses who would otherwise need to use multiple 5mg vials.
Effects and Benefits
- Significant appetite reduction supporting substantial reductions in food intake
- Slowed gastric emptying contributing to prolonged satiety after meals
- Improved insulin sensitivity and glucose regulation
- Higher per-vial concentration reduces the number of vials needed for advanced maintenance protocols
- No suppression of natural testosterone — does not require Post Cycle Therapy
Dosage and Administration
| Phase | Typical Dose | Notes |
|---|---|---|
| Standard maintenance | 5 mg/week | Half the 10mg vial per dose |
| Advanced maintenance | 7.5 mg/week | Three-quarters of the 10mg vial |
| High-dose maintenance | 10 mg/week | Full vial content per dose |
Tirzepatide remains dosed once weekly via subcutaneous injection regardless of vial strength. The 10mg vial is intended for users who have already titrated upward through the standard schedule (typically starting at 2.5mg and increasing every 4 weeks) and are now maintaining at 7.5mg/week or above. Users beginning Tirzepatide for the first time should generally start with the 5mg Tirze-Pep vial, as the initial titration doses are well below this concentration.
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
Comments (0)
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent